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Abstract
Sepsis is a life-threatening organ dysfunction that is 
caused by the body’s dysregulated response to an 
infection. A crucial component of treatment includes 
intravenous antibiotic administration and is 
recommended within 1 hour of suspected sepsis. 
However, research conducted over the past two 
decades have produced mixed results regarding the 
relationship between mortality rates and this 1 hour 
time limit. In light of issues such as increasing 
antibiotic resistance and limited resources in 
emergency departments, this study reviewed current 
literature to critically evaluate the effects of modest 
delays in antibiotic administration in sepsis and 
septic shock. 
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● Up until 2016, sepsis was defined as infection 
with at least 2 of the 4 SIRS (Systemic 
Inflammatory Response Syndrome) criteria: 
1) temperature >38°C or <36°C
2) heart rate >90/min
3) respiratory rate >20/min or PaCO2 <32 
mmHg
4) white blood cell count >12,000/mm3 or 
10% immature bands.
• In the United States alone, more than 970,000 
cases of sepsis are admitted a year and are 
responsible for more than 50% of all hospital 
deaths.
• The Surviving Sepsis Campaign strongly 
recommends the administration of broad-
spectrum IV antibiotics within one hour of 
recognition for both sepsis and septic shock.
Introduction
Methods
• PubMed and EBSCOhost were used to perform 
literature searches using terms antibiotics, sepsis, 
septic shock, mortality, and timing.
• Inclusion criteria included adult populations, from 
peer reviewed journals, and written in English.
• Exclusion criteria included systemic reviews, 
replies or commentaries, studies that focused on 
additional diseases or disorders (e.g. cholecystitis), 
and articles published greater than 5 years prior to 
the search was performed.
• A total a 6 articles were chosen for this study. 
• 2/6 studies that did not find an 
association between timing to antibiotic 
administration and mortality. They were 
also the first prospective and the first 
randomized controlled studies 
conducted in the body of literature. 
• They do, however, have smaller sample 
sizes, but they still create a foundation 
upon future research can be built.
• 4/6 studies report increased in-hospital 
mortality with delays in antibiotic 
administration in patients with sepsis or 
septic shock.
• However, a closer look at the results 
shows inconclusive data with regards 
to differences in outcomes when 
antibiotics are given within 1, 2, 3, and 
even 4 hours in sepsis or severe 
sepsis, but not septic shock. 
• These 4 studies were also retrospectively 
conducted, which potentially introduced 
various levels of bias and other 
confounding factors. 
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While additional research must be 
conducted, these studies suggest that 
delays of up to 4 hours may not significantly 
affect mortality in patients with sepsis. 
However, delays are detrimental in those 
with septic shock. Majority of the studies 
were retrospectively conducted, indicating a 
need for continued research with regards to 
the most effective treatment of sepsis at all 
levels of severity. Further research is also 
needed to investigate the appropriateness 
of the antibiotics given since the increasing 
prevalence of antibiotic resistance remains 
an issue.
Conclusion
Results
1. de Groot B, Ansems A, Gerling DH, et al. The association between time to antibiotics and relevant clinical outcomes in 
emergency department patients with various stages of sepsis: A prospective multi-center study. 
A reduction in time to antibiotics was not found to be associated with a reduction in 28-day mortality or hospital length 
of stay.
2. Alam N, Oskam E, Stassen PM, et al. Prehospital antibiotics in the ambulance for sepsis: A multicenter, open label, 
randomized trial. 
Giving prehospital antibiotics led to a time gain of 96 minutes, but did not lead to a difference in in-hospital, 28 day, or 
90 day mortality.
3. Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic 
shock from the first hour: Results from a guideline-based performance improvement program. 
As time to antibiotic administration increased, the adjusted hospital mortality odds ratios increased from 1.00 to 1.52. 
However, for hours 1 through 3, the p-value is >0.05, indicating lack of statistical significance of these time frames, 
bringing to question the importance of antibiotic administration within 1 hour of presentation versus 3 hours. 
4. Liu VX, Fielding-Singh V, Greene JD, et al. The timing of early antibiotics and hospital mortality in sepsis. 
Each elapsed hour until antibiotic administration was associated with a 9% increase in the odds of mortality. The effect 
was largest for patients with septic shock at a 14% increase in the odds of mortality. Confidence intervals for the odds 
ratios between 2 and 5 hours overlapped which could suggest that modest delays in antibiotics may not substantially 
increase mortality in patients with mild to moderate sepsis.
5. Seymour CW, Gesten F, Prescot HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. 
The odds ratio of mortality until antibiotics were administered was calculated to be 1.04 per hour for the first 3 hours in 
patient with severe sepsis and septic shock. However, this data was collected after implementation of mandatory 
statewide sepsis protocol, and is potentially confounded by more adherent hospitals also providing overall better levels 
of care.
6. Pruinelli L, Westra BL, Yadav P, et al. Delay within the 3-hour Surviving Sepsis Campaign guideline on mortality for 
patients with severe sepsis and septic shock. 
In-hospital mortality increased with delay in antibiotics, but only became statistically significant at nearly 3 hours after 
baseline.
Study Design Total N
Population 
Demographics
Severity of 
Sepsis
Intervals of Abx 
Administration
Outcomes Measured
1
Prospective 
observational cohort 
study
1,168
650 men
518 women
Mild, moderate, 
severe
Within 1 hour, between 1 
and 3 hours, and after 3 
hours
In-hospital mortality, mortality 
after 28 days after initial 
presentation, length of 
hospital stay
2
Randomized 
controlled trial
2,672
1,535 men
1,137 women
Non-severe 
sepsis, severe 
sepsis, septic 
shock
Time in minutes to 
antibiotics in the 
emergency department; 
time in minutes to 
antibiotics before hospital 
arrival
All-cause mortality at 28 days, 
in-hospital  mortality and 
within 90 days, length of 
hospital stay, quality of life 1 
month after discharge
3
Retrospective cohort 
study
28,150
N/A Severe, septic 
shock
1-hour time periods up to 6 
hours
In-hospital mortality, length of 
hospital stay
4 Retrospective study 35,000
16,961 men
18,039 women
Sepsis, severe 
sepsis, septic 
shock
1-hour time periods up to 6 
hours
In-hospital mortality
5 Retrospective study 49,331
N/A Sepsis, septic 
shock
Time in hours from 
initiation of sepsis protocol
In-hospital mortality
6
Retrospective cohort 
study
5,072
2,588 men
2,484 women
Severe sepsis, 
septic shock
Minutes from onset of 
sepsis (baseline)
In-hospital mortality
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